Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$19.21 /

+0.2 (+1.05%)

04:55
02/11/20
02/11
04:55
02/11/20
04:55

Exelixis management to meet with SunTrust

Group Dinner Meeting to be held in New York on February 11 hosted by SunTrust.

  • 11

    Feb

  • 11

    Feb

  • 11

    Feb

  • 13

    Feb

EXEL Exelixis
$19.21 /

+0.2 (+1.05%)

01/13/20 SunTrust
Exelixis initiated with a Buy at SunTrust
01/12/20 Piper Sandler
Exelixis shares to trade lower on guidance, says Piper Sandler
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
11/13/19 BofA
Exelixis initiated with a Buy at BofA/Merrill

TODAY'S FREE FLY STORIES

Hot Stocks
Teva presents data evaluating AJOVY experience in difficult-to-treat migraine » 16:38
05/25/20
05/25
16:38
05/25/20
16:38
TEVA

Teva

$11.97 /

-0.05 (-0.42%)

Teva Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

05/11/20 UBS
Teva price target raised to ILS 15 from ILS 12 at UBS
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Teva initiated with a Neutral at Citi
04/06/20 UBS
Teva upgraded to Buy from Neutral at UBS
TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

Hot Stocks
Churchill Downs, Aristocrat announce agreement in principle to settle lawsuits » 16:33
05/25/20
05/25
16:33
05/25/20
16:33
CHDN

Churchill Downs

$122.35 /

+4.15 (+3.51%)

, ARLUF

Aristocrat Leisure

$0.00 /

+ (+0.00%)

Churchill Downs (CHDN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
03/02/20 JPMorgan
Golden Entertainment downgraded to Neutral on downside risk at JPMorgan
03/02/20 JPMorgan
JPMorgan upgrades Churchill Downs on overblown COVID-19 concerns
03/02/20 JPMorgan
Churchill Downs upgraded to Overweight from Neutral at JPMorgan
ARLUF Aristocrat Leisure
$0.00 /

+ (+0.00%)

03/29/20 Goldman Sachs
Aristocrat Leisure upgraded to Buy from Neutral at Goldman Sachs
03/02/20 Credit Suisse
Aristocrat Leisure upgraded to Outperform from Neutral at Credit Suisse
10/28/19 Credit Suisse
Aristocrat Leisure downgraded to Neutral from Outperform at Credit Suisse
CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

Hot Stocks
Regeneron to repurchase $5B of shares directly from Sanofi » 13:49
05/25/20
05/25
13:49
05/25/20
13:49
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

Regeneron Pharmaceuticals…

Regeneron Pharmaceuticals (REGN) announced that subject to and immediately following the close of its secondary offering, Regeneron agreed to repurchase approximately $5B of common stock directly from Sanofi (SNY). The purchase price to be paid by Regeneron will be equal to the net offering price per share after deducting any underwriters' discount and commission. Regeneron will fund the purchase with a combination of $3.5B of cash on hand and $1.5 billion of fully-committed bridge financing from Goldman Sachs Bank USA.

ShowHide Related Items >><<
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

Syndicate
Regeneron announces secondary offering for Sanofi sale of 12.8M shares » 13:48
05/25/20
05/25
13:48
05/25/20
13:48
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

Hot Stocks
Sanofi to sell investment in Regeneron, says will not impact collaboration » 13:45
05/25/20
05/25
13:45
05/25/20
13:45
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

Sanofi (SNY) announced…

Sanofi (SNY) announced its intent to sell its equity investment in Regeneron Pharmaceuticals (REGN) through a registered public offering and related share repurchase by Regeneron. The registered offering and share repurchase will have no impact on the ongoing collaboration between Sanofi and Regeneron, the company said in a statement. A preliminary prospectus supplement relating to the offering of Regeneron's shares will be filed with the SEC. Sanofi currently holds approximately 23.2M shares of Regeneron's common stock, representing approximately 20.6% ownership. Regeneron has agreed to repurchase $5B of its stock from Sanofi conditional on completion of the proposed public offering. If the offering and repurchase are completed and the underwriters fully exercise their option to purchase additional shares, Sanofi will continue to own approximately 400,000 shares of Regeneron's common stock, which Sanofi is retaining in support of the ongoing collaboration with Regeneron. "Sanofi and Regeneron's collaboration has been one of the most productive in the industry, creating significant value for both companies but more importantly, resulting in five important medicines for patients. Sanofi remains committed to continuing our collaboration with Regeneron which remains an integral part of our overall strategy, and this decision was fully aligned with Regeneron, said Paul Hudson, Chief Executive Officer, Sanofi. "The decision to divest our holdings is consistent with our efforts to enhance value creation for our shareholders. We believe the proceeds from this transaction will help further our ability to execute on our strategy to drive innovation and growth."

ShowHide Related Items >><<
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

General news
U.S. Week Ahead » 11:35
05/25/20
05/25
11:35
05/25/20
11:35

U.S. Week Ahead: Growth,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Oil Action: July WTI futures are up 0.5% » 09:55
05/25/20
05/25
09:55
05/25/20
09:55

Oil Action: July WTI…

Oil Action: July WTI futures are up 0.5% at $33.43, which is just over 30 cents below the intraday high. The market is consolidating recent gains after prices peaked last week at a near-11-week high at $34.66, which was the culmination of four consecutive up weeks. Market conditions are thin in the absence of London markets today, and with U.S. markets closed. An FT on a report detailed a sharp drop in U.S. oil output, with further declines expected later in 2020, with many oil mining operations there having been rendered unviable at prevailing prices. This chimes with last Friday's weekly Baker-Hughes rig count, which revealed another 21 oil rigs were shuttered in the U.S., to bring the the tally to 237 after what is now the 10th straight week of closures. Recent dips in oil inventories have also illustrated shifting fundamentals, with reopening economies around the world stimulating more demand, just as supply continues to ebb.

Recommendations
AMC Networks price target lowered to $28 from $35 at Goldman Sachs » 08:34
05/25/20
05/25
08:34
05/25/20
08:34
AMCX

AMC Networks

$29.11 /

-1.63 (-5.30%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

05/19/20 Imperial Capital
Hard to believe strategic buyer interested in AMC Networks, says Imperial
04/27/20 RBC Capital
AMC Networks initiated with an Outperform at RBC Capital
04/24/20 Imperial Capital
AMC Networks price target lowered to $25 from $33 at Imperial Capital
02/27/20 Wells Fargo
AMC Networks price target lowered to $35 from $46 at Wells Fargo
AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

Upgrade
KDDI upgraded to Neutral from Sell at Citi » 08:31
05/25/20
05/25
08:31
05/25/20
08:31
KDDIY

KDDI

$0.00 /

+ (+0.00%)

Citi upgraded KDDI to…

Citi upgraded KDDI to Neutral from Sell with a 3,100 yen price target.

ShowHide Related Items >><<
KDDIY KDDI
$0.00 /

+ (+0.00%)

KDDIY KDDI
$0.00 /

+ (+0.00%)

03/17/20 Deutsche Bank
KDDI upgraded to Buy from Hold at Deutsche Bank
12/19/19 JPMorgan
KDDI upgraded to Overweight from Neutral at JPMorgan
06/18/19 JPMorgan
KDDI upgraded to Neutral from Underweight at JPMorgan
KDDIY KDDI
$0.00 /

+ (+0.00%)

Downgrade
Pinduoduo downgraded to Hold from Buy at Jefferies » 08:31
05/25/20
05/25
08:31
05/25/20
08:31
PDD

Pinduoduo

$68.72 /

+8.68 (+14.46%)

Jefferies analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

05/24/20 Goldman Sachs
Pinduoduo downgraded to Neutral from Buy at Goldman Sachs
05/22/20 CLSA
Pinduoduo price target raised to $72 from $46.50 at CLSA
05/20/20 BofA
Pinduoduo downgraded to Neutral from Buy at BofA
04/29/20 KeyBanc
Pinduoduo price target raised to $65 from $50 at KeyBanc
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

Upgrade
Telekom Malaysia upgraded to Outperform from Underperform at Credit Suisse » 08:28
05/25/20
05/25
08:28
05/25/20
08:28
MYTEF

Telekom Malaysia

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Credit Suisse analyst Danny Chen double upgraded Telekom Malaysia to Outperform from Underperform with a MYR 5.50 price target.

Upgrade
Insurance Australia upgraded to Outperform from Neutral at Credit Suisse » 08:25
05/25/20
05/25
08:25
05/25/20
08:25
IAUGY

Insurance Australia

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Canadian Utilities upgraded to Buy from Hold at Industrial Alliance » 08:24
05/25/20
05/25
08:24
05/25/20
08:24
CDUAF

Canadian Utilities

$0.00 /

+ (+0.00%)

Industrial Alliance…

Industrial Alliance analyst Elias Foscolos upgraded Canadian Utilities to Buy from Hold with a C$36 price target.

ShowHide Related Items >><<
CDUAF Canadian Utilities
$0.00 /

+ (+0.00%)

CDUAF Canadian Utilities
$0.00 /

+ (+0.00%)

05/04/20 BMO Capital
Canadian Utilities price target lowered to C$35 from C$36 at BMO Capital
04/23/20 Credit Suisse
Canadian Utilities downgraded to Neutral from Outperform at Credit Suisse
03/31/20 TD Securities
Canadian Utilities upgraded to Buy from Hold at TD Securities
11/01/19 TD Securities
Canadian Utilities downgraded to Hold from Buy at TD Securities
Upgrade
TC Energy upgraded to Buy from Hold at Industrial Alliance » 08:23
05/25/20
05/25
08:23
05/25/20
08:23
TRP

TC Energy

$42.13 /

+0.61 (+1.47%)

Industrial Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$42.13 /

+0.61 (+1.47%)

TRP TC Energy
$42.13 /

+0.61 (+1.47%)

05/13/20
Fly Intel: Top five analyst downgrades
05/12/20 BMO Capital
TC Energy downgraded to Market Perform from Outperform at BMO Capital
05/12/20
Fly Intel: Top five analyst initiations
05/12/20 Jefferies
TC Energy initiated with a Hold at Jefferies
TRP TC Energy
$42.13 /

+0.61 (+1.47%)

TRP TC Energy
$42.13 /

+0.61 (+1.47%)

Downgrade
Parkland downgraded to Hold from Buy at Industrial Alliance » 08:23
05/25/20
05/25
08:23
05/25/20
08:23
PKIUF

Parkland

$0.00 /

+ (+0.00%)

Industrial Alliance…

Industrial Alliance analyst Elias Foscolos downgraded Parkland to Hold from Buy with a C$40 price target.

ShowHide Related Items >><<
PKIUF Parkland
$0.00 /

+ (+0.00%)

PKIUF Parkland
$0.00 /

+ (+0.00%)

05/08/20 Scotiabank
Parkland Fuel price target lowered to C$40 from C$42 at Scotiabank
05/07/20 RBC Capital
Parkland Fuel price target raised to C$38 from C$35 at RBC Capital
03/24/20 RBC Capital
Parkland Fuel price target lowered to C$35 from C$46 at RBC Capital
03/09/20 BMO Capital
Parkland Fuel attractive after stock decline, says BMO Capital
Upgrade
FirstService upgraded to Buy from Hold at TD Securities » 08:20
05/25/20
05/25
08:20
05/25/20
08:20
FSV

FirstService

$87.40 /

-0.61 (-0.69%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSV FirstService
$87.40 /

-0.61 (-0.69%)

FSV FirstService
$87.40 /

-0.61 (-0.69%)

04/27/20 RBC Capital
FirstService price target lowered to $95 from $112 at RBC Capital
04/24/20
Fly Intel: Top five analyst upgrades
04/24/20 William Blair
FirstService upgraded to Outperform from Market Perform at William Blair
04/23/20 William Blair
FirstService upgraded to Outperform from Market Perform at William Blair
FSV FirstService
$87.40 /

-0.61 (-0.69%)

Initiation
Tabcorp initiated with a Sell at Citi » 08:18
05/25/20
05/25
08:18
05/25/20
08:18
TACBY

Tabcorp

$0.00 /

+ (+0.00%)

Citi initiated coverage…

Citi initiated coverage of Tabcorp with a Sell rating and A$2.80 price target.

General news
European stock markets rallied, » 06:55
05/25/20
05/25
06:55
05/25/20
06:55

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar has remained buoyant » 06:55
05/25/20
05/25
06:55
05/25/20
06:55

FX Update: The dollar has…

FX Update: The dollar has remained buoyant amid narrow ranges in early-week trading so far. Conditions will be thin today with both UK and U.S. markets out for public holidays. Tensions between the U.S. and China continued to build over the weekend. Amid the developments, the U.S. will be adding anther 33 Chinese companies and institutions to an economic blacklist on the accusation that they are helping China spy. The White House national security adviser, meanwhile, said economic sanctions would likely be imposed on Hong Kong and China if Beijing moved ahead with its proposed national security law for Hong Kong. Beijing, for its part, said it will not back down from the "technology war mongering" while warning of "ample countermeasures." The narrow trade-weighted USD index edged out a one-week high at 99.93, while EUR-USD ebbed to a one-week low at 1.0875. USD-JPY matched Friday's high at 107.78, though didn't breach it. AUD-USD settled in the lower 0.6500s, above the 0.6506 low that was seen on Friday. USD-CAD consolidated gains seen in the latter part of last week, which on Friday left a one-week high at 1.4050. The pair settled near the 1.4000 mark. Oil prices are moderately firmer today, though remain off the 11-week highs seen last week. In stock markets, the Nikkei 225 rallied 1.7% and posted its highest daily close since March 6th, while the Hang Seng and China's main indices traded in the red, though pared losses during the PM session. On the coronavirus front, focus remains on reopening economies and a rebound in economic activity. Brazil remains a rapidly emerging hotspot, and now has the second highest level of confirmed cases, behind the U.S.

Conference/Events
Carlisle management to meet virtually with Oppenheimer » 04:55
05/25/20
05/25
04:55
05/25/20
04:55
CSL

Carlisle

$115.50 /

-1.01 (-0.87%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSL Carlisle
$115.50 /

-1.01 (-0.87%)

CSL Carlisle
$115.50 /

-1.01 (-0.87%)

04/17/20 Jefferies
Carlisle initiated with a Buy at Jefferies
01/21/20 Oppenheimer
Carlisle price target raised to $177 from $170 at Oppenheimer
01/14/20 Berenberg
Carlisle initiated with a Buy at Berenberg
01/07/20 Loop Capital
Carlisle initiated with a Hold at Loop Capital
CSL Carlisle
$115.50 /

-1.01 (-0.87%)

General news
FX Action: USD-CAD has consolidated gains » 04:00
05/25/20
05/25
04:00
05/25/20
04:00

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Action: The dollar has remained buoyant amid narrow ranges » 03:25
05/25/20
05/25
03:25
05/25/20
03:25

FX Action: The dollar has…

FX Action: The dollar has remained buoyant amid narrow ranges in early-week trading so far. Conditions will be thin today with both UK and U.S. markets out for public holidays. Tensions between the U.S. and China continued to build over the weekend. Amid the developments, the U.S. will be adding anther 33 Chinese companies and institutions to an economic blacklist on the accusation that they are helping China spy. The White House national security adviser, meanwhile, said economic sanctions would likely be imposed on Hong Kong and China if Beijing moved ahead with its proposed national security law for Hong Kong. Beijing, for its part, said it will not back down from the "technology war mongering" while warning of "ample countermeasures." The narrow trade-weighted USD index edged out a one-week high at 99.93, while EUR-USD ebbed to a one-week low at 1.0875. USD-JPY matched Friday's high at 107.78, though didn't breach it. AUD-USD settled in the lower 0.6500s, above the 0.6506 low that was seen on Friday. USD-CAD consolidated gains seen in the latter part of last week, which on Friday left a one-week high at 1.4050. The pair settled near the 1.4000 mark. Oil prices are moderately firmer today, though remain off the 11-week highs seen last week. In stock markets, the Nikkei 225 rallied 1.7% and posted its highest daily close since March 6th, while the Hang Seng and China's main indices traded in the red, though pared losses during the PM session. On the coronavirus front, focus remains on reopening economies and a rebound in economic activity. Brazil remains a rapidly emerging hotspot, and now has the second highest level of confirmed cases, behind the U.S.

General news
Asian Market Update: » 03:05
05/25/20
05/25
03:05
05/25/20
03:05

Asian Market Update: With…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Pinduoduo downgraded to Neutral from Buy at Goldman Sachs » 19:23
05/24/20
05/24
19:23
05/24/20
19:23
PDD

Pinduoduo

$68.72 /

+8.68 (+14.46%)

Goldman Sachs analyst…

Goldman Sachs analyst Piyush Mubayi downgraded Pinduoduo to Neutral from Buy with a price target of $62.70, up from $54. The stock closed Friday up $8.70 to $68.70. After rallying 239% in the past year, shares of Pinduoduo reflect its "unique value proposition" to online shoppers in China, Mubayi tells investors in a research note. The analyst remains positive on the company's longer-term earnings growth outlook and believes it remains well positioned to capture the "continuous rising tide" in e-commerce post COVID-19. However, Mubayi sees "limited valuation attraction" at current share levels.

ShowHide Related Items >><<
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

05/22/20 CLSA
Pinduoduo price target raised to $72 from $46.50 at CLSA
05/20/20 BofA
Pinduoduo downgraded to Neutral from Buy at BofA
04/29/20 KeyBanc
Pinduoduo price target raised to $65 from $50 at KeyBanc
04/20/20 Credit Suisse
Pinduoduo upgraded to Outperform from Neutral at Credit Suisse
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

Hot Stocks
iQIYI launches S-diamond Membership package » 16:10
05/24/20
05/24
16:10
05/24/20
16:10
IQ

iQIYI

$15.50 /

-1.01 (-6.12%)

iQIYI launched its…

iQIYI launched its S-diamond Membership package, "catering to users' desire for free control over how they view content on a wider range of devices and their growing diverse needs for content-related services," according to the company. The S-diamond Membership entitles members to a wide range of benefits and premium services, including early access to on-demand drama episodes and S-diamond Cinema's films at no extra cost; integrated content offerings of the existing Gold Membership, Galaxy QIYI Guo S-diamond Membership, FUN Membership, Literature Membership, VR Membership and Sports Membership-General programs; access through multiple devices including mobile devices, PC, Internet TV, tablets, and VR devices. iQIYI will also be launching an S-diamond Cinema for films, providing S-diamond members free access to top-rated paid domestic and international films at no extra cost. S-diamond members will also be able to "enjoy the entertainment experiences across smartphones, tablets, computers, Internet TV and VR devices, anywhere, anytime. Whether viewers choose to watch as a family on a large screen in the living room or privately during their commute, or become totally immersed in the VR world, iQIYI S-diamond members will enjoy highly engaging viewing experiences," the company added.

ShowHide Related Items >><<
IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

05/20/20 HSBC
iQIYI price target lowered to $23 from $32 at HSBC
04/14/20
Fly Intel: Top five analyst initiations
04/13/20 Oppenheimer
iQIYI initiated with an Outperform at Oppenheimer
04/09/20 Mizuho
Baidu concerns overstated, current valuation 'compelling,' says Mizuho
IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

IQ iQIYI
$15.50 /

-1.01 (-6.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.